Table 2 Susceptibilities
| Antimicrobial | Number susceptible (n = 108) |
|---|---|
| New agents | |
| Cefiderocol | 108 (100%) |
| Ceftazidime-avibactam | 108 (100%) |
| Ceftolozane-tazobactam | 105 (97%) |
| Fosfomycin | 104 (96%) |
| Plazomicin | 108 (100%) |
| Standard agents | |
| Amikacin | 108 (100%) |
| Gentamicin | 72 (67%) |
| Tobramycin | 61 (56%) |
| Piperacillin-tazobactam | 99 (92%) |
| Ceftazidime | 46 (43%) |
| Ceftriaxone | 0 (0%) |
| Ertapenem | 103 (95%) |
| Meropenem | 108 (100%) |
| Ciprofloxacin | 43 (40%) |
| Trimethoprim-sulfamethoxazole | 44 (41%) |